New MRI technique could reveal how well lung treatments are working

NCT ID NCT06012500

Ongoing Diagnosis Sponsor: Children's Hospital Medical Center, Cincinnati Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a special MRI technique using inhaled xenon gas to better see changes in the lungs of people with interstitial lung disease. Researchers want to make the method consistent across different hospitals and MRI machines. The goal is to help doctors quickly tell if a treatment is working, without invasive procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Xenon-129 (inhaled contrast for MRI)
What this could lead to: If successful, this could make 129Xe MRI a reliable tool to see how well lung treatments are working, helping doctors personalize care for interstitial lung disease.
What could go wrong: This is an early-phase study focused on imaging methods, not a treatment. It may not lead to direct patient benefits, and results may vary across different MRI machines.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ILD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

interstitial lung disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ILD

Contacts and locations

Locations

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.